These 4 Stocks Have Value Stock Metrics – And Momentum Stock Upside!
“These are four quality stocks to buy that have value characteristics but also appear to have the hidden potential to have momentum stock upside,” says…
davidgoldstein
New Stocks To Watch In Tech And Biotech (And Mining, Sports & Restaurants)
Tech companies involved in the software, cloud computing, mobile app and telecom sectors are among the new tech stocks to watch highlighted in today’s article,…
These 2 Healthcare Stocks That Achieved Price Highs In The Past Year May Be Best Avoided Now
Like many healthcare stocks, the two discussed in today’s article hit price highs over the past year. Unlike many healthcare stocks, however, they didn’t necessarily…
A Sober Look At This Psychedelic Stock
Amid growing acceptance of the use of psychedelic drugs for treating mental disorders, the clinical-stage biotech company featured in today’s article, which has a pipeline…
A Strong Product Pipeline, Solid Upside And Attractive Valuation Could Make This Biotech A Buy
With nine FDA-approved products and more than 30 product candidates in clinical development – including a potential COVID-19 therapeutic – the biotechnology company featured in…
Even SPAC Skeptics Are Intrigued By This One
While the contributors to today’s article are not necessarily fans of blank check special purpose acquisition companies (SPACs), they cannot help but be intrigued by…
Should These 3 Biotech Stocks Be Excised From Your Portfolio?
When it comes to the three biotech stocks discussed in today’s article, all of which are down 45% or more from their 52-week highs, should…
Biotech Opportunities And Risks In Q2 – And Beyond
After a challenging first quarter of 2021 for biotech investors, what does the second quarter – and, beyond that, the second half of 2021 –…
Select Stocks For The Semiconductor Shortage
There’s a severe shortage of semiconductors – the worst shortage in 30 years according to one analysis – and it’s being felt across many industries,…
How To Approach “Extraordinarily Risky” Clinical-Stage Biotech Stocks
“Investing in any kind of stock can be risky. But investing in clinical-stage biotech stocks can be extraordinarily risky,” acknowledge the authors of today’s article.…